SS Innovations International, Inc. (NASDAQ: SSII) announced it has been awarded the Outstanding Company category at the 2026 Surgical Robotics Industry Awards. The award recognizes a company demonstrating excellence in innovation, commercial success, industry leadership and positive societal impact. According to the company, the award reflects growing adoption of its SSi Mantra surgical robotic system, which it believes is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency.
As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The company also said approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries.
The award and the growing procedure volume signal that SS Innovations is making headway in its mission to make robotic surgery affordable and accessible globally. The SSi Mantra system, along with its suite of SSi Mudra surgical instruments, supports a variety of procedures including cardiac surgery. The company, an American company headquartered in India, plans to expand the global presence of its solutions.
For more details, the full press release is available at https://ibn.fm/XWdRe.
